What we know
What we don’t know
Most but not all eFAD mutations appear to increase Abeta42, or to increase the ratio
of Abeta42 to Abeta40
Do eFAD mutations cause AD through a gain of toxic function, or by the loss of an
important normal function? Are there Abeta-independent effects of eFAD mutations?